Runners and riders in the Covid vaccine race

Pfizer, AstraZeneca and Moderna have received acceptance for their Covid vaccines from the United kingdom regulator and the jabs are previously staying rolled out. But what about the other vaccine candidates and how soon will they come to industry?

Our listing offers a snapshot of what the vaccine landscape appears to be like.

The life sciences industry’s response to the pandemic has been unparalleled both equally in phrases of the pace at which it has made vaccines and its willingness to collaborate with rivals. That has resulted in 237 potential vaccines, of which 64 are in human clinical trials.

That’s fantastic information as, in the vaccines business there is generally no “one particular-dimensions-suits-all” solution, with distinct countries demanding distinct sorts of vaccines dependent on a vary of variables including local weather, land mass and demography. In other words and phrases: there is a good deal of place in the industry for far more than one particular vaccine.

Covid vaccines accredited by the United kingdom


United kingdom acceptance date: December 2, 2020

Doses: 2

Efficacy: 90pc +

Form: mRNA

Doses sold or pre-ordered globally: The total sum is undisclosed, but we know it has 300m on purchase from the EU and 200m from the US, which, alongside one another with the United kingdom, delivers the total to 540m

Doses procured by the United kingdom: 40m

Producing functionality: Up to 2bn doses this 12 months